(Q41703122)

English

A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.

scientific article published on November 1999

Statements

A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS. (English)
0 references
1 November 1999
3267-3273

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit